GlassScriptPhysician profile
Shari Tomasetti
NPI 1972717973
$13,747.01
in general payments reported to CMS, 2019-2025
51 companies · $3,307 in 2025
The $3,307 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,513 · 2022: $2,701 · 2023: $2,661 · 2024: $3,566 · 2025: $3,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,409 · Education: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,409.33 |
| Education | $124.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,605.19 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $1,411.66 | 2021-2025 | Evenity, Repatha, Prolia |
| Lilly USA, LLC | $1,351.53 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,073.22 | 2021-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $1,041.10 | 2021-2025 | |
| Abbvie INC. | $736.11 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $721.50 | 2021-2025 | |
| Xeris Pharmaceuticals, INC. | $690.61 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Mannkind Corporation | $592.79 | 2022-2025 | Afrezza |
| Insulet Corporation | $586.34 | 2021-2025 | Omnipod |
| Tolmar, INC. | $528.85 | 2023-2025 | Jatenzo |
| Astrazeneca Pharmaceuticals LP | $514.13 | 2021-2025 | Farxiga, Lokelma |
| Esperion Therapeutics, INC. | $347.60 | 2021-2025 | Nexletol |
| Medtronic, INC. | $290.17 | 2021-2025 | Minimed 780g, Intellis Adaptivestim |
| Corcept Therapeutics | $267.48 | 2021-2025 | Korlym |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $251.45 | 2024-2025 | Veozah |
| Antares Pharma, INC. | $232.39 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Cequr Corporation | $131.38 | 2023-2025 | Cequr Simplicity |
| Shield Therapeutics INC | $113.11 | 2023-2024 | Accrufer |
| Verity Pharmaceuticals INC. | $104.37 | 2024-2025 | Tlando |
| Otsuka America Pharmaceutical, INC. | $98.28 | 2022-2023 | Jynarque |
| Alexion Pharmaceuticals, INC. | $88.14 | 2022-2025 | Strensiq |
| Abbott Laboratories | $67.71 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Ascendis Pharma Endocrinology INC | $66.26 | 2025 | Yorvipath |
| Pfizer INC. | $65.28 | 2022-2024 | |
| Lifescan, INC. | $61.15 | 2021 | |
| Merck Sharp & Dohme LLC | $45.75 | 2021 | |
| Halozyme INC | $45.46 | 2023 | |
| Dexcom, INC. | $45.31 | 2024-2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $44.90 | 2024 | |
| Kyowa Kirin, INC. | $43.38 | 2024 | Crysvita |
| Tandem Diabetes Care, INC. | $41.26 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Calliditas Therapeutics US INC. | $41.14 | 2022-2024 | |
| Ardelyx, INC. | $38.20 | 2024-2025 | Ibsrela |
| E.R. Squibb & Sons, L.L.C. | $36.35 | 2022 | |
| Nevro Corp. | $34.78 | 2024 | Senza |
| Sequel Med Tech, LLC | $25.83 | 2025 | Twiist |
| Acadia Pharmaceuticals INC | $25.82 | 2025 | Nuplazid |
| Alnylam Pharmaceuticals INC. | $25.60 | 2024 | Onpattro |
| Beta Bionics, INC. | $22.88 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Glaxosmithkline, LLC. | $22.43 | 2025 | Arexvy, Shingrix |
| Ionis Pharmaceuticals, INC. | $21.59 | 2025 | Tryngolza |
| Travere Therapeutics, INC. | $20.64 | 2023 | |
| Averitas Pharma INC. | $19.50 | 2023 | Qutenza |
| Ascensia Diabetes Care US INC. | $19.04 | 2021 | |
| Vifor Pharma, INC. | $17.89 | 2021 | |
| Alfasigma USA, INC. | $17.67 | 2021 | |
| Acerus Pharmaceuticals Corporation | $16.97 | 2022 | |
| Madrigal Pharmaceuticals | $16.85 | 2025 | Rezdiffra |
| Regeneron Healthcare Solutions, INC. | $14.95 | 2021 | |
| Genentech USA, INC. | $5.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shari Tomasetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.